The Essure birth control device has faced growing scrutiny due to serious and long-term side effect reports.
It was originally marketed as a permanent, non-surgical birth control option for women.
However, rising safety concerns have triggered multiple FDA labeling changes, investigations, and public warnings.

The most commonly reported complications from the Essure birth control device include chronic pelvic pain and pain during sexual activity. Other symptoms include persistent headaches, mood disorders such as anxiety or depression, abnormal bleeding, and in some cases, hair loss. Some women also experienced allergic reactions to the materials used in the device, particularly to metals like nickel. In more severe situations, the device shifted from its original position, leading to organ perforation or unintended pregnancy. These complications have sometimes required surgical removal of the device to relieve symptoms or prevent additional harm.

The U.S. Food and Drug Administration (FDA) has received thousands of complaints about the Essure birth control device. It continues to review reports and assess the long-term safety of the product. Although the FDA issued labeling updates, including a black box warning and a patient checklist, serious safety concerns remain. The manufacturer stopped selling the device in the United States in 2018. However, many women who previously received the implant continue to report serious and lasting health issues.